GYRE Competitors & Alternatives
Compare Gyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
GYRE
Main Stock$5.86
Tradestie Score
53
Market Cap
$688.47M
Revenue Growth
0.0%
Analyst Upside
+218.5%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANL
ANL
|
$11.33
|
$656.86M | - | 51 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$14.43
|
$626.91M | - | 53 | Compare |
|
SVRA
Savara Inc.
|
$5.33
|
$611.84M | - | 60 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.04
|
$552.46M | - | 51 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$11.90
|
$540.97M | - | 56 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$12.55
|
$529.35M | 6.5 | 64 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.96
|
$512.39M | - | 53 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$33.42
|
$505.12M | 1.7 | 65 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$93.51
|
$492.21M | - | 50 | Compare |
More GYRE Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry